Skip to main content
Jeffrey Hausfeld, MD, Otolaryngology (ENT), Potomac, MD

JeffreyNealHausfeldMDM.B.A.

Otolaryngology (ENT) Potomac, MD

Cofounder: The Society of Physician Entrepreneurs; President, Memory Care Communities of Illinois

Dr. Hausfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hausfeld's full profile

Already have an account?

  • Office

    1 Lehavre Court
    Potomac, MD 20854
    Phone+1 301-340-1131

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityMBA, Business of Medicine, 2001 - 2005
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1979 - 1982
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Transitional Year, 1978 - 1979
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1978 - 1978
  • Yale School of Medicine
    Yale School of MedicineClass of 1978

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1982 - 2026
  • DC State Medical License
    DC State Medical License 1982 - 2006
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • BioFactura Announces the Appointment of Jeffrey N. Hausfeld MD, MBA as the Chairman of the Board and Chief Medical Officer
    BioFactura Announces the Appointment of Jeffrey N. Hausfeld MD, MBA as the Chairman of the Board and Chief Medical OfficerSeptember 17th, 2015
  • BioFactura Is on Course to Become a Global Leader in Biosimilar Development
    BioFactura Is on Course to Become a Global Leader in Biosimilar DevelopmentSeptember 29th, 2021

Professional Memberships

Other Languages

  • Spanish, Hebrew